Gad Getz

351.4k citations

225 papers · 42.6k indexed · 21 hit papers · h-index 74

Impact in

Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 0.05%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases

Papers in

Cancer Research 108
- Cancer Genomics and Diagnostics 96
Genetics 36
- Chronic Lymphocytic Leukemia Research 27

Co-authors: Matthew Meyerson Todd R. Golub Scott L. Carter Michael S. Lawrence Rameen Beroukhim Craig H. Mermel Stacey Gabriel Benjamin L. Ebert
Journals: Blood (39 papers)Cancer Research (29 papers)Journal of Clinical Oncology (15 papers)Bioinformatics (11 papers)Nature Genetics (9 papers)
Partner nations: United States Israel Germany

In The Last Decade

Gad Getz

214 papers receiving 42.1k citations

Hit Papers

15 papers align trajectories log scale

CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours 2022 · 225 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature
2019 Science
2018 PLoS Medicine
2016 Nature Reviews Clinical Oncology
2015 Cell
2014 Nature
2014 Nature Genetics
2014 Blood
2013 Nature Genetics
2013 Nature Genetics
2013 Nature Genetics
2013 Nature Communications
2012 Bioinformatics
2012 Nature Biotechnology
2011 Genome biology
2010 Nature Reviews Genetics
2005 Nature
2005 Nature
2005 Nature
2004 Bioinformatics
2000 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Gad Getz

Since Specialization

Citations

This map shows the geographic impact of Gad Getz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gad Getz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gad Getz more than expected).

Fields of papers citing papers by Gad Getz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gad Getz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gad Getz. The network helps show where Gad Getz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gad Getz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gad Getz Line = papers co-authored together Gad Getz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical models Nature Communications ·O. Michel, Mehmet Seyfettin Sarıbaş, Frank Gomberg, Amanda A. Bouffard, Eel-Deok Oh, Sefanur AKYILDIZ, Chengjie Bai, Mark B. Leick, Nicholas J. Haradhvala, Yadong Huang, Gad Getz, Giulia Escobar, Diego Salas‐Benito, Adele Mucci, Trisha R. Berger, Marcela V. Maus	2025	0
2	Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma Clinical Cancer Research ·Dickran Kazandjian, Benjamin Diamond, Д. Todorova, Byeoung Soo Park, Romanos Sklavenitis‐Pistofidis, Bachisio Ziccheddu, Patrick Blaney, Monika Chojnacka, Michael Durante, Kylee Maclachlan, Ryan M. Young, Saad Z. Usmani, Faith E. Davies, Gad Getz, Irene M. Ghobrial, Neha Korde, Gareth J. Morgan, Francesco Maura, Ola Landgren	2024	5
3	Nectin-4 expression in primary breast cancer and associated clinical outcomes. Journal of Clinical Oncology ·Arielle J. Medford, Andrzej Niemierko, Rachel O. Abelman, Nicholas J. Haradhvala, 悟小宮山, Laura M. Spring, Gad Getz, Aditya Bardia	2024	0
4	DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma Blood ·Bjoern Chapuy, Timothy R. Wood, Chip Stewart, Andrew Dunford, Kirsty Wienand, Théophane Piette, 강호원, Amar B. Belazoug, 鲍嘉龄, Joji Shimono, Stanislav V. Naranovich, Sam M. Wiseman, Е.Л. СТРИЖАКОВ, David I. Heiman, Robert Redd, Margaret A. Shipp, Gad Getz	2024	2
5	Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors Clinical Cancer Research ·Joseph Toker, J. Bryan Iorgulescu, Alexander Ling, Genaro R. Villa, Ashraf M. Megahed, Laxmi Parida, Gad Getz, Catherine J. Wu, David A. Reardon, E. Antonio Chiocca, Marco Mineo	2023	27
6	Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis Nature Communications ·S Mahesh Kumar, Nicholas J. Haradhvala, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Tarek H. Mouhieddine, Oksana Zavidij, Ming‐Chieh Shih, U. GOTTWICK, Mendy Miller, Habib El‐Khoury, Shankara Anand, François Aguet, David Sontag, Irene M. Ghobrial, Gad Getz	2022	31
7	Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History Cancer Discovery ·Livius Penter, Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang, Shuqiang Li, Wandi Zhang, Dimitri Livitz, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Laura Z. Rassenti, Thomas J. Kipps, Jennifer R. Brown, Matthew S. Davids, Donna Neuberg, Kenneth J. Livak, Vijay G. Sankaran, Catherine J. Wu	2021	45
8	RNA-SeQC 2: efficient RNA-seq quality control and quantification for large cohorts Bioinformatics ·Aaron Graubert, François Aguet, Arvind Ravi, Kristin Ardlie, Gad Getz	2021	47
9	Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling Nature Biotechnology ·Caleb A. Lareau, Leif S. Ludwig, Christoph Muus, Satyen H. Gohil, Tongtong Zhao, Zachary Chiang, Karin Pelka, Jeffrey M. Verboon, Wendy Luo, Elena Christian, Daniel Rosebrock, Gad Getz, Genevieve M. Boland, Fei Chen, Jason D. Buenrostro, Nir Hacohen, Catherine J. Wu, Martin J. Aryee, Aviv Regev, Vijay G. Sankaran	2020	178
10	Predicting and affecting response to cancer therapy based on pathway-level biomarkers Nature Communications ·Rotem Ben‐Hamo, A. Berger, Nancy Gavert, Mendy Miller, Guy Pines, Roni Oren, Eli Pikarsky, Cyril H. Benes, Tzahi Neuman, Yaara Zwang, Sol Efroni, Gad Getz, Ravid Straussman	2020	52
11	Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma Clinical Cancer Research ·Ali Amin‐Mansour, Suzanne George, Stefano Sioletic, Scott L. Carter, Mara Rosenberg, Amaro Taylor‐Weiner, Chip Stewart, Aaron Chevalier, Sara Seepo, Adam Tracy, Gad Getz, Jason L. Hornick, Marisa R. Nucci, Bradley J. Quade, George D. Demetri, Chandrajit P. Raut, Levi A. Garraway, Eliezer M. Van Allen, Andrew J. Wagner	2019	18
12	RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues Science ·Keren Yizhak, François Aguet, Jaegil Kim, Julian M. Hess, Kirsten Kübler, Jonna Grimsby, Georg Leidenberger Jost, Hailei Zhang, Nicholas J. Haradhvala, Daniel Rosebrock, Dimitri Livitz, Xiao Li, Christina Schües, Noam Shoresh, Chip Stewart, Ayellet V. Segrè, Philip A. Branton, Paz Polak, Kristin Ardlie, Gad Getz Hit paper breakdown →	2019	310
13	SvABA: genome-wide detection of structural variants and indels by local assembly Genome Research ·Jeremiah A. Wala, Pratiti Bandopadhayay, Noah F. Greenwald, Ryan O’Rourke, Ted Sharpe, Chip Stewart, Steve Schumacher, Yilong Li, Joachim Weischenfeldt, Xiaotong Yao, Chad Nusbaum, Peter J. Campbell, Gad Getz, Matthew Meyerson, Cheng‐Zhong Zhang, Marcin Imieliński, Rameen Beroukhim	2018	181
14	Comparison of algorithms for the detection of cancer drivers at subgene resolution Nature Methods ·Eduard Porta‐Pardo, Atanas Kamburov, David Tamborero, Tirso Pons, 周连顺, Alfonso Valencia, Núria López-Bigas, Gad Getz, Adam Godzik	2017	53
15	Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma Clinical Cancer Research ·Kent W. Mouw, James M. Cleary, Brendan Reardon, Ose HANKO, Lior Z. Braunstein, Jaegil Kim, Ali Amin‐Mansour, Diana Miao, 杨京楠, Joanna Chin, Patrick A. Ott, Charles S. Fuchs, Neil E. Martin, Gad Getz, Scott L. Carter, Harvey J. Mamon, Jason L. Hornick, Eliezer M. Van Allen, Alan D. D’Andrea	2016	36
16	Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation Clinical Cancer Research ·Lijian Yu, Haesook T. Kim, Siddha Kasar, Cecilia Buchta, Wei Du, Christina Schmalz, Andrew Aw, Bethany Tesar, Reina Improgo, Stacey M. Fernandes, 小田和美, Josephine L. Klitgaard, Charles Lee, Gad Getz, Sunita R. Setlur, Jennifer R. Brown	2016	62
17	Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development PLoS Genetics ·Krinio Giannikou, Izabela A. Malinowska, Trevor J. Pugh, Rachel Yan, Yuen‐Yi Tseng, Coyin Oh, Jaegil Kim, Magdalena E. Tyburczy, Yvonne Chekaluk, Yang Liu, Nicola Alesi, Geraldine A. Finlay, Chin‐Lee Wu, Sabina Signoretti, Matthew Meyerson, Gad Getz, Jesse S. Boehm, Elizabeth P. Henske, David J. Kwiatkowski	2016	85
18	Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer Clinical Cancer Research ·Dariush Etemadmoghadam, George Au‐Yeung, Meaghan Wall, Thomas J. Mitchell, Maya Kansara, Elizabeth Loehrer, RE Osman, Joshy George, Sarah Ftouni, Barbara A. Weir, Scott L. Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C. Hahn, Paul Waring, Gad Getz, Carleen Cullinane, Lynda J. Campbell, David D.L. Bowtell	2013	90
19	Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Cancer Research ·Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha, Matthew D. Wilkerson, Andrey Sivachenko, Ellen M. Beauchamp, Qingsong Liu, Trevor J. Pugh, Chandra Sekhar Pedamallu, D. Neil Hayes, Nathanael S. Gray, Gad Getz, Kwok‐Kin Wong, Robert I. Haddad, Matthew Meyerson, Peter S. Hammerman	2013	134
20	Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma Cancer Research ·William M. Lin, Alissa C. Baker, Rameen Beroukhim, Wendy Winckler, Whei Feng, Mathan Siegrist, Elisabeth Laine, Heidi Greulich, Hsiuyi Tseng, Casey Gates, F. Stephen Hodi, Glenn Dranoff, William R. Sellers, Roman K. Thomas, Matthew Meyerson, Todd R. Golub, Reinhard Dummer, Meenhard Herlyn, Gad Getz, Levi A. Garraway	2008	215

About Gad Getz

Gad Getz is a scholar working on Cancer Research, Genetics, Pathology and Forensic Medicine, Molecular Biology and Hematology, having authored 225 papers that have together received 42.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (96 papers), Chronic Lymphocytic Leukemia Research (27 papers), Genetic factors in colorectal cancer (23 papers), RNA modifications and cancer (19 papers), Bioinformatics and Genomic Networks (19 papers), Gene expression and cancer classification (17 papers), Epigenetics and DNA Methylation (17 papers) and Genomics and Phylogenetic Studies (16 papers). The work is most often cited by research in Cancer Research (18.7k citations), Molecular Biology (27.7k citations), Oncology (10.6k citations), Pulmonary and Respiratory Medicine (8.1k citations) and Immunology (5.0k citations). Gad Getz has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Matthew Meyerson, Todd R. Golub, Scott L. Carter, Michael S. Lawrence, Rameen Beroukhim, Craig H. Mermel, Stacey Gabriel, Benjamin L. Ebert, Catherine J. Wu and Eric A. Miska. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology, Bioinformatics and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact